Erratum: Effect of introducing xpert MTB/RIF to test and treat individuals at risk of multidrug-resistant tuberculosis in Kazakhstan: A prospective cohort study (PLoS ONE (2015) 10:7 (e0132514) DOI: 10.1371/journal.pone.0132514)

Sanne Christine Van Kampen; Aigul Tursynbayeva; Aliya Koptleuova; Zauresh Murzakhmetova; Lyazzat Bigalieva; Moldir Aubakirova; Svetlana Pak; Susan Van Den Hof

ArticleOPEN ACCESS

Erratum: Effect of introducing xpert MTB/RIF to test and treat individuals at risk of multidrug-resistant tuberculosis in Kazakhstan: A prospective cohort study (PLoS ONE (2015) 10:7 (e0132514) DOI: 10.1371/journal.pone.0132514)

PLoS ONE

DOI: 10.1371/journal.pone.0136368

2Citations

14Readers

Cite

CITATION STYLE

APA

Van Kampen, S. C., Tursynbayeva, A., Koptleuova, A., Murzakhmetova, Z., Bigalieva, L., Aubakirova, M., … Van Den Hof, S. (2015, August 19). Erratum: Effect of introducing xpert MTB/RIF to test and treat individuals at risk of multidrug-resistant tuberculosis in Kazakhstan: A prospective cohort study (PLoS ONE (2015) 10:7 (e0132514) DOI: 10.1371/journal.pone.0132514). PLoS ONE. Public Library of Science. https://doi.org/10.1371/journal.pone.0136368

Erratum: Effect of introducing xpert MTB/RIF to test and treat individuals at risk of multidrug-resistant tuberculosis in Kazakhstan: A prospective cohort study (PLoS ONE (2015) 10:7 (e0132514) DOI: 10.1371/journal.pone.0132514)

Cite

Register to see more suggestions